For the Inventor, By the Inventor

Enter assignee name

Phc Corporation

USPTO Granted Patents = 36

% Expired Patents = 11.1

EPO Patents = 13

Trademarks = 3

Forward Citations = 72

Loading Chart...

Loading Chart...

80 inventors (with patents filed for the assignee):

Hirokazu Sanada (13 out of 20 patents)

Hironori Omura (13 out of 21 patents)

Takako Yada (13 out of 22 patents)

4. Tetsunari Morita (13 out of 17 patents)

5. Ayaka Atsumi (9 out of 12 patents)

6. Emi Ishimaru (9 out of 13 patents)

7. Mika Kuyama (4 out of 5 patents)

8. Tokuji Ikeda (4 out of 9 patents)

9. Kenji Kano (4 out of 9 patents)

10. Seiya Tsujimura (4 out of 6 patents)

11. Eiichi Mori (3 out of 7 patents)

12. Yoshiaki Iida (3 out of 10 patents)

13. Eiji Doi (3 out of 6 patents)

14. Hikaru Aoki (3 out of 3 patents)

15. Hiroki Hirai (3 out of 3 patents)

Core Competencies:

Analyte Meters

Refrigeration Apparatus

Platelet Activation

Information Management

Testing Instruments

Coenzyme-Linked Glucose Dehydrogenase

Incubator

Pharmaceutical Injection Device

Cold Storage

Risk Stratification

Atomization Device

Compositions for Skin Disorders

36 patents: Sort by Forward Citations

1. 12722151 - Analyte meters, test strip ejectors, and methods of using same (2026-09-01),

2. 12638219 - Refrigeration apparatus with non-azeotropic refrigerant mixture (2026-05-26),

3. 12590978 - Method for measuring platelet activation based on soluble CLEC-2 and platelet count (2026-03-31),

4. 12505904 - Information management apparatus and non-transitory computer-readable recording medium (2025-12-23),

5. D1103414 - Control panel for laboratory apparatus (2025-11-25),

6. 12436161 - Analysis device, analysis method, and analysis program (2025-10-07),

7. D1094772 - Testing instrument (2025-09-23),

8. 12422439 - Use of sCD14 or its fragments or derivatives for risk stratification, diagnosis and prognosis (2025-09-23),

9. 12371648 - Atomization device and culture device (2025-07-29),

10. 12297419 - Culture device (2025-05-13),

11. 12180455 - Culture device (2024-12-31),

12. 12085327 - Cold storage (2024-09-10),

13. 12044460 - Cold storage (2024-07-23),

14. 12018755 - Seal structure of cold storage and cold storage (2024-06-25),

15. 11345897 - Coenzyme-binding glucose dehydrogenase (2022-05-31),

PHC Corporation, headquartered in Ehime, Japan, specializes in the development and manufacturing of advanced medical devices and healthcare solutions. The company focuses on innovative technologies in areas such as diagnostics, laboratory equipment, and healthcare IT systems, aiming to enhance patient care and streamline medical processes. With a commitment to research and development, PHC Corporation plays a significant role in the global healthcare landscape, contributing to improved health outcomes through its cutting-edge products and services.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Phc Corporation

36 Patents

#7 in Ehime

#2,098 in Japan

#18,697 in the World

Phc Corporation

Forward Citations = 72

80 inventors:

Hirokazu Sanada (13 out of 20 patents)

Hironori Omura (13 out of 21 patents)

Takako Yada (13 out of 22 patents)

4. Tetsunari Morita (13 out of 17 patents)

5. Ayaka Atsumi (9 out of 12 patents)

Please report any incorrect information to [email protected]

Loading…